Urgent action is needed to address the rising malarial treatment resistance in eastern Africa, a recent Policy Forum has warned.
Artemisinin-based combination therapies (ACTs), first recommended by the World Health Organisation in 2006, have been the cornerstone of malaria treatment and control for over a decade, and have played a crucial role in reducing the global burden of malaria.
